HUM Stock Summary and Trading Ideas (Humana | NYSE:HUM)

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Humana trades on the NYSE stock market under the symbol HUM.

As of November 4, 2026, HUM stock price climbed to $418.77 with 717,980 million shares trading.

HUM has a beta of 1.30, meaning it tends to be more sensitive to market movements. HUM has a correlation of 0.09 to the broad based SPY ETF.

HUM has a market cap of $50.28 billion. This is considered a Large Cap stock.

Last quarter Humana reported $41 billion in Revenue and $7.61 earnings per share. This beat revenue expectation by $310 million and exceeded earnings estimates by $.80.

In the last 3 years, HUM traded as high as $527.18 and as low as $163.11.

The top ETF exchange traded funds that HUM belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.

HUM has outperformed the market in the last year with a return of +50.9%, while the SPY ETF gained +13.5%. In the last 3 month period, HUM beat the market returning +12.1%, while SPY returned +1.7%. However, in the most recent 2 weeks HUM has underperformed the stock market by returning -1.8%, while SPY returned -0.1%.

HUM support price is $406.67 and resistance is $429.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HUM shares will trade within this expected range on the day.